Mukund S. Chorghade
Mukund S. Chorghade earned his B.S. and M.S. degrees from the University of Poona in India as well as a Ph.D. degree in organic chemistry at Georgetown University in Washington, DC, USA. He completed his postdoctoral appointments at the Universities of Virginia and Harvard and his visiting scientist appointments at University of British Columbia, College de France/Université Louis Pasteur, and Caltech. Moreover, he directed research groups at Dow Chemicals, Abbott Laboratories, CytoMed, and Genzyme. A recipient of three Scientist of the Year Awards, he is an Elected Fellow of The American Chemical Society (ACS), The American Association for the Advancement of Science (AAAS), and The Royal Society of Chemistry (RSC) and has been a featured speaker in several national and international symposia. He is active in ACS, for example, he was the Chair of The Northeastern Section of the American Chemical Society (NESACS) and Brazosport College Chair, and he also serves on the International Activities Committee. Dr. Chorghade is the President of Chorghade Enterprises and the Chief Scientific Officer at THINQ Pharma. He provides consultations to pharmaceutical researchers on collaborations with academic, government, and industrial laboratories. He advises technology-based companies on process re-engineering and project management of technology transfer, establishes strategic partnerships, and conducts cGLP/cGMP compliance training and implementation in chemical laboratories. He oversees projects in medicinal chemistry, chemical route selection, process development, and manufacturing and formulation of bulk actives to finished dosage forms.
Biography Updated on 4 October 2010